By analysing the relationship between KCNH2 expression levels and the levels of 3 types of RNA methylation modifications, we found that KCNH2 was associated with almost the expression levels of almost all assessed writers, erasers, and readers in the 4 tumour types NB, GBM, PCPG, and OV. Here, KCNH2 is linked to glioblastoma.